Beijing Da Xue Xue Bao 46, 379382
The products of this company are not intended to diagnose, treat, cure, or prevent any medical condition or disease
Canagliflozin reduced the risk of the primary composite outcome (ESKD, doubling of serum creatinine, or renal or cardiovascular death) by 30% compared to placebo, with consistent effects across all prespecified subgroups [46]
Asia Pac J Clin Nutr (2003) 12(4):48894
Researchers studying tendon, ligament, and cartilage repair have evaluated GH-axis amplification as a mechanism for accelerating extracellular matrix remodeling
GHK-Cu Side Effects & Safety GHK-Cu has a long topical safety record and a shorter, mostly anecdotal injectable record